Snowball logo
logo
  • Stocks
  • China
  • Materials
3011

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd

301130 • SHE
¥25.71+¥0.30  (1.18%)
Estimate
P/E
85.7
EPS
0.3
Beta
0.469
Growth
Revenue, YoY
7.1%
Net income, YoY
10.74%
FCF, YoY
0.88%
Dividends
Dividend yield
0.56%
Annual payout
¥0.15
Next ex. div date
June 1, 27
Payout
88.74%
Div.rating
About the company
Ticker
301130
ISIN
CNE1000058C4
Country
China
Sector (GICS)
Materials
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research, development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anti-anemia, mental disorders, circulatory disorders, anti-psychotic, active pharmaceutical ingredients, and antidepressant medication. It also provides iron supplements and blood tonics; psychotropic drugs; cardiovascular system medication; medication for chronic diseases in the elderly; cancer adjuvant drugs; cardiovascular and cerebrovascular drugs; cold medicine; and other products. The company was founded in 1990 and is headquartered in Panshi, China.

Frequently asked questions

What sector does Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) operate in?

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd belongs to the Materials sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) current stock price?

As of the latest data, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd stock price is CN¥25.71, with a previous close of CN¥25.41. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd gained CN¥0.30 in the last trading session, representing a 1.18% increase.

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) current market capitalization?

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd market cap is approximately 1.97 billion.

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.30.

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) Price-to-Earnings (P/E) ratio?

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd current P/E ratio is 85.7.

Does Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) pay dividends?

Yes. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd pays annual dividends with an annualized yield of 0.56% and an estimated annual payout of CN¥0.15 per share.

When is the next ex-dividend date for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130)?

The next ex-dividend date is scheduled for June 01, 2027.

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) beta (volatility) score?

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd has a beta of 0.469, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.